BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28659334)

  • 41. Composite marginal zone B cell lymphoma and enteropathy-type T cell lymphoma of the stomach: a case report.
    Yun WK; Ko YH; Kim DS; Kim WS; Rhee PL; Kwak SY; Jang TH; Choi WS
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):791-5. PubMed ID: 18617785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma.
    Tirier C; Zhang Y; Plendl H; Weber-Matthiesen K; Langer W; Heit W; Schlegelberger B
    Leukemia; 1996 Feb; 10(2):346-50. PubMed ID: 8637246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.
    Kawamoto S; Yamamoto K; Toyoda M; Yakushijin K; Matsuoka H; Minami H
    Int J Hematol; 2017 Feb; 105(2):226-229. PubMed ID: 27686674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concomitant translocation t(14;22)(q32;q11) in a case of chronic myeloid leukemia.
    Orciuolo E; Buda G; Galimberti S; Cecconi N; Cervetti G; Petrini M
    Leuk Res; 2008 Jan; 32(1):188-90. PubMed ID: 17346791
    [No Abstract]   [Full Text] [Related]  

  • 45. Peripheral T-cell lymphoma: a developing concept.
    Pileri SA; Ascani S; Sabattini E; Falini B
    Ann Oncol; 1998 Aug; 9(8):797-801. PubMed ID: 9789599
    [No Abstract]   [Full Text] [Related]  

  • 46. Mutations of epigenetic genes and correlation with treatment response in peripheral T-cell lymphoma.
    Wei C; Wang W; Li W; Zhang Y; Zhao D; Zhang W; Zhou D
    Clin Transl Med; 2024 Jan; 14(1):e1491. PubMed ID: 38239088
    [No Abstract]   [Full Text] [Related]  

  • 47. Mutual regulation between BCL6 and a specific set of miRNAs controls T
    Manso R; Martínez-Magunacelaya N; Chamizo C; Rojo F; Piris MÁ; Rodriguez-Pinilla SM
    Br J Haematol; 2018 Aug; 182(4):587-590. PubMed ID: 28699695
    [No Abstract]   [Full Text] [Related]  

  • 48. Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study.
    Maruyama D; Tobinai K; Ogura M; Uchida T; Hatake K; Taniwaki M; Ando K; Tsukasaki K; Ishida T; Kobayashi N; Ishizawa K; Tatsumi Y; Kato K; Kiguchi T; Ikezoe T; Laille E; Ro T; Tamakoshi H; Sakurai S; Ohtsu T
    Int J Hematol; 2017 Nov; 106(5):655-665. PubMed ID: 28664499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report.
    Chen S; Nagel S; Schneider B; Dai H; Geffers R; Kaufmann M; Meyer C; Pommerenke C; Thress KS; Li J; Quentmeier H; Drexler HG; MacLeod RAF
    Cell Oncol (Dordr); 2018 Feb; 41(1):93-101. PubMed ID: 29119387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.
    Daver N; Kantarjian H; Garcia-Manero G; Jabbour E; Borthakur G; Brandt M; Pierce S; Vaughan K; Ning J; Nogueras González GM; Patel K; Jorgensen J; Pemmaraju N; Kadia T; Konopleva M; Andreeff M; DiNardo C; Cortes J; Ward R; Craig A; Ravandi F
    Haematologica; 2017 Oct; 102(10):1709-1717. PubMed ID: 28729302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. JSH Guideline for Tumors of Hematopoietic and Lymphoid Tissues: Leukemia: 6. Myelodysplastic syndromes (MDS).
    Miyazaki Y
    Int J Hematol; 2017 Aug; 106(2):151-159. PubMed ID: 28677111
    [No Abstract]   [Full Text] [Related]  

  • 52. Genome-wide methylation profiling of Peripheral T-cell lymphomas identifies TRIP13 as a critical driver of tumor proliferation and survival.
    Nowialis P; Tobon J; Lopusna K; Opavska J; Badar A; Chen D; Abdelghany R; Pozas G; Fingeret J; Noel E; Riva A; Fujiwara H; Opavsky R
    Res Sq; 2024 Feb; ():. PubMed ID: 38464090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.
    Jiang B; Weinstock DM; Donovan KA; Sun HW; Wolfe A; Amaka S; Donaldson NL; Wu G; Jiang Y; Wilcox RA; Fischer ES; Gray NS; Wu W
    Cell Chem Biol; 2023 Apr; 30(4):383-393.e6. PubMed ID: 37015223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
    Herek TA; Bouska A; Lone W; Sharma S; Amador C; Heavican TB; Li Y; Wei Q; Jochum D; Greiner TC; Smith L; Pileri S; Feldman AL; Rosenwald A; Ott G; Lim ST; Ong CK; Song J; Jaffe ES; Wang GG; Staudt L; Rimsza LM; Vose J; d'Amore F; Weisenburger DD; Chan WC; Iqbal J
    Blood; 2022 Sep; 140(11):1278-1290. PubMed ID: 35639959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral T-cell lymphoma cell line T8ML-1 highlights conspicuous targeting of PVRL2 by t(14;19)(q11.2;q13.3).
    Ehrentraut S; Nagel S; Pommerenke C; Dirks WG; Quentmeier H; Kaufmann M; Meyer C; Zaborski M; Geffers R; Fujiwara H; Drexler HG; MacLeod RAF
    Haematologica; 2017 Sep; 102(9):e356-e359. PubMed ID: 28659334
    [No Abstract]   [Full Text] [Related]  

  • 56. A rare case of Lennert's type peripheral T-cell lymphoma with t(14;19)(q11.2;q13.3).
    Shin SY; Jang S; Park CJ; Chi HS; Lee KH; Huh J; Seo EJ
    Int J Lab Hematol; 2012 Jun; 34(3):328-32. PubMed ID: 22122800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PVRL2 is translocated to the TRA@ locus in t(14;19)(q11;q13)-positive peripheral T-cell lymphomas.
    Almire C; Bertrand P; Ruminy P; Maingonnat C; Wlodarska I; Martín-Subero JI; Siebert R; Tilly H; Bastard C
    Genes Chromosomes Cancer; 2007 Nov; 46(11):1011-8. PubMed ID: 17696193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly.
    Somja J; Bisig B; Bonnet C; Herens C; Siebert R; de Leval L
    Virchows Arch; 2014 Jun; 464(6):735-41. PubMed ID: 24604141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Recent advance in peripheral T-cell lymphoma, not otherwise specified].
    Duan R; Zhang JZ
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):427-9. PubMed ID: 21055168
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cytogenetics of malignant lymphomas].
    Schlegelberger B
    Verh Dtsch Ges Pathol; 1992; 76():60-5. PubMed ID: 1283277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.